Shionogi’s Dr. Draica on why COVID-19 still matters — and why the window between exposure and symptoms is where XOCOVA can intervene.
Dr. Florin Draica
Advertisement
Florin Draica is senior vice president of US medical affairs at Shionogi.
Articles by Dr. Florin Draica
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease
2
AI Twins Are Growing in the Pharma Industry
3
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
4
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
5